EnsembleIQ today announces the launch of the GLP-1 Shopper Summit, a new one-day industry event that will bring together senior leaders from retail, CPG, data and technology organizations to examine how GLP-1 adoption is changing the shopper and what those changes mean for merchandising, product innovation, shopper engagement and business growth
We use the model to simulate the metabolic profiles previously observed in Down syndrome and autism and compare the model results to clinical data
The rationale for including them is there, since several have theoretical links to GLP-1 secretion or metabolism
Saxenda 3 mg daily for weight management): Proven efficacy with 5-8% weight reduction and cardiovascular outcome benefits in the LEADER trial Dulaglutide (Trulicity 0.75-4.5 mg weekly): Convenient once-weekly dosing with demonstrated cardiovascular benefit in the REWIND trial Tirzepatide (Mounjaro for diabetes
Queremos que todos tengan acceso a este gran tratamiento
La FDA ha establecido indicaciones especficas: para diabetes tipo 2, como adyuvante a dieta y ejercicio para mejorar el control glucmico